Showing results (1521-1530 of 8,962) with videos related to

Sort By:
Pageof 897
Journal of Hepatology|June 3, 2014
Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosisIsabel Gómez-Hurtado, Alba Moratalla, Ángela Moya-Pérez, et al.
Journal of Hepatology|June 3, 2014
Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapiesRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Journal of Hepatology|July 11, 2020
Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitisAmédée Renand, Iñaki Cervera-Marzal, Laurine Gil, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Journal of Hepatology|April 12, 2021
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolatesWenshi Wang, Florian A Lempp, Franziska Schlund, et al.
Journal of Hepatology|August 23, 2020
Simultaneous splenectomy improves outcomes after adult living donor liver transplantationTomoharu Yoshizumi, Shinji Itoh, Mototsugu Shimokawa, et al.
Journal of Hepatology|August 1, 1988
Differential effect of alpha-interferons on CD4- and CD8-positive lymphocytes in chronic hepatitis B virus carriersK T Nouri-Aria, G J Alexander, S Magrin, et al.
Journal of Hepatology|February 1, 1988
Isolation and culture of Kupffer cells from human liver. Ultrastructure, endocytosis and prostaglandin synthesisA Brouwer, R J Barelds, A M de Leeuw, et al.
Journal of Hepatology|August 11, 2020
Hepatic benefits of HCV cureVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|April 22, 2021
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedAdrián Vallejo, Oihane Erice, Rodrigo Entrialgo-Cadierno, et al.
Pageof 897